Novartis wins FDA breakthrough therapy for AML treatment

ZURICH (Reuters) - Novartis received breakthrough therapy designation from the U.S. Food and Drug Administration for an investigational treatment for newly-diagnosed FLT3-mutated acute myeloid leukemia, the Swiss drugmaker said on Friday.

http://ift.tt/20I0tDm

from Reuters: Health News
via animenewspro